Knud Norregaard Hansen
Overview
Explore the profile of Knud Norregaard Hansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansen K, Antonsen L, Maehara A, Maeng M, Ellert J, Ahlehoff O, et al.
Cardiovasc Revasc Med
. 2020 Oct;
30:50-58.
PMID: 33012685
Objectives: To compare the early vascular healing of ruptured plaques (RP) and non-ruptured plaques (NRP) one month after primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction...
2.
Jensen L, Maeng M, Raungaard B, Kahlert J, Ellert J, Jakobsen L, et al.
Circulation
. 2020 May;
141(25):2052-2063.
PMID: 32434381
Background: In patients with increased bleeding risk, the biolimus A9-coated BioFreedom stent, a stainless steel drug-coated stent free from polymer, has shown superiority compared with a bare-metal stent. The aim...
3.
Ellert J, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, et al.
Coron Artery Dis
. 2020 Apr;
31(6):485-492.
PMID: 32271243
Background: Drug-eluting stents with biodegradable polymers have been designed to improve safety and efficacy. However, drug-eluting stents with biodegradable polymers may not be a class effect, as stent strut thickness,...
4.
Maeng M, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, et al.
JACC Cardiovasc Interv
. 2019 Apr;
12(7):624-633.
PMID: 30947936
Objectives: The aim of this study was to compare the thin-strut biodegradable-polymer everolimus-eluting platinum-chromium stent (EES) with the biodegradable-polymer biolimus-eluting stainless-steel stent (BES). Background: Currently available drug-eluting coronary stents have...
5.
Brabrand M, Hansen K, Laursen C, Larsen T, Vestergaard H, Abildgaard N
Eur J Haematol
. 2018 Nov;
102(3):227-234.
PMID: 30450659
Objective: Pulmonary hypertension (PH) has been reported to be associated with myeloproliferative neoplasms (MPN), affecting 5%-48% of MPN patients. With the aims to describe the prevalence of PH in Ph-MPN...
6.
Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, et al.
EuroIntervention
. 2017 Sep;
13(13):1587-1590.
PMID: 28870882
No abstract available.
7.
Noori M, Thayssen P, Veien K, Junker A, Hansen K, Hansen H, et al.
Cardiovasc Revasc Med
. 2017 Jan;
18(3):182-189.
PMID: 28109718
Introduction: Near-infrared spectroscopy (NIRS) is a new method to identify lipid core plaque (LCP). The LCP and vascular response were assessed with NIRS to examine whether LCP was compressed or...
8.
Antonsen L, Thayssen P, Hansen H, Junker A, Veien K, Hansen K, et al.
Int J Cardiol
. 2016 Aug;
223:466-474.
PMID: 27544607
Background: Stenting-induced edge dissections (ED) can be assessed in detail by optical coherence tomography (OCT). This study sought to investigate the incidence, morphological characteristics, and spontaneous healing course of OCT-identified...
9.
Jensen L, Thayssen P, Maeng M, Ravkilde J, Krusell L, Raungaard B, et al.
Circ Cardiovasc Interv
. 2016 Jul;
9(7).
PMID: 27412869
Background: Coronary drug-eluting stents with biodegradable polymers have been designed to improve safety and efficacy. Methods And Results: The Scandinavian Organization for Randomized Trials With Clinical Outcome (SORT OUT) VII...
10.
Jensen L, Thayssen P, Christiansen E, Maeng M, Ravkilde J, Hansen K, et al.
J Am Coll Cardiol
. 2016 Feb;
67(7):751-62.
PMID: 26892409
Background: Long-term safety and efficacy for everolimus-eluting stents (EES) versus those of sirolimus-eluting stents (SES) are unknown. Objectives: This study compared 5-year outcomes for EES with those for SES from...